In terms of the mechanism, some groups reported that inhibition of Bcl9 can overcome resistance to immune checkpoint blockades by decreasing Treg cells and increasing the CD8+ T cells in CRC [53,54]. Here, BCL9 is linked to colorectal carcinoma.